{
  "titre": "Borréliose de Lyme",
  "description": "Stades cliniques et antibiothérapie adaptée.",
  "auteur": "Dr I. Kahn",
  "version": "2022.1",
  "dateModification": "2022-09-01T00:00:00.000Z",
  "blocs": [
    {
      "type": "section",
      "ordre": 1,
      "titre": "1. Erythème Migrant (Phase I)",
      "initialementOuvert": true,
      "contenu": [
        {
          "type": "medicament",
          "ordre": 0,
          "nomMedicament": "Amoxicilline",
          "indication": "1ère intention",
          "voie": "PO",
          "commentaire": "50 mg/kg/j en 3 prises. 14 jours."
        },
        {
          "type": "medicament",
          "ordre": 1,
          "nomMedicament": "Doxycycline",
          "indication": "Si > 8 ans",
          "voie": "PO",
          "commentaire": "4 mg/kg/j en 2 prises. 14 jours."
        }
      ]
    },
    {
      "type": "section",
      "ordre": 2,
      "titre": "2. Neuroborréliose (Phase II)",
      "contenu": [
        {
          "type": "texte",
          "ordre": 0,
          "contenu": "Paralysie faciale, Méningite lymphocytaire."
        },
        {
          "type": "medicament",
          "ordre": 1,
          "nomMedicament": "Ceftriaxone",
          "indication": "Neuroborréliose",
          "voie": "IV",
          "commentaire": "80 mg/kg/j (Max 2g). 21 à 28 jours."
        }
      ]
    }
  ]
}
